Preconditioning with low doses of ligands for TLR2, TLR4, and TLR9 all successfully reduce infarct size in experimental models of stroke [19-21], including a recent study showing that a TLR9 ligand is neuroprotective in a nonhuman primate model of stroke [22]. This evidence concerns the gene TLR9 and Stroke.